Long-term efficacy and safety of the interleukin-1 inhibitors anakinra and canakinumab in a patient with refractory Behçet's disease uveitis and concomitant bladder papillary carcinoma

Donato Rigante

Risultato della ricerca: Contributo in rivista › Articolo in rivista

6 Citazioni (Scopus)

Fingerprint

Entra nei temi di ricerca di 'Long-term efficacy and safety of the interleukin-1 inhibitors anakinra and canakinumab in a patient with refractory Behçet's disease uveitis and concomitant bladder papillary carcinoma'. Insieme formano una fingerprint unica.

Medicine and Dentistry